ANSLF Stock Chart & Stats
$20.10
-$0.03(-0.13%)
At close: 4:00 PM EST
$20.10
-$0.03(-0.13%)
Day’s Range― - ―
52-Week Range$16.03 - $26.39
Previous CloseN/A
Volume200.00
Average Volume (3M)6.00
Market Cap
$3.12B
Enterprise Value$6.00K
Total Cash (Recent Filing)$254.17M
Total Debt (Recent Filing)$912.82M
Price to Earnings (P/E)23.1
Beta0.71
Next Earnings
Aug 24, 2026EPS Estimate
0.76Next Dividend Ex-DateN/A
Dividend Yield2.53%
Share Statistics
EPS (TTM)0.96
Shares Outstanding140,313,830
10 Day Avg. Volume0
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio1.53
Price to Book (P/B)1.47
Price to Sales (P/S)1.45
P/FCF Ratio17.03
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$23.20Price Target Upside15.41% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)1.08
Revenue Forecast (FY)$1.52B
Bulls Say, Bears Say
Bulls Say
Margin Expansion And Operational LeverageAnsell delivered sustained margin expansion driven by pricing, procurement savings and integration synergies. Higher mid-teens EBIT performance indicates improved cost structure and pricing power that can sustain cash flow and buffer against cyclical volume softness over the next 2–6 months.
Strong Cash Conversion And Moderate Leverage112% cash conversion and modest leverage provide durable financial flexibility: supports ongoing capex, buybacks and working capital needs while keeping headroom for tariff or FX shocks. A solid equity base reduces refinancing risk and underpins investment capacity.
Product Innovation And Manufacturing ExpansionNew differentiated products and added surgical capacity in India diversify supply, lower unit costs and expand addressable markets (industrial, scientific, cleanroom). These structural moves support higher-margin growth and reduce reliance on single geographies or suppliers.
Bears Say
Material Tariff Exposure And Market DisruptionAn $80M annualized tariff is a persistent structural headwind that may force sustained price increases. While management targets full offset via pricing/mitigation, higher end-prices can permanently reduce volume in price-sensitive markets and erode long-term market share.
Volume Weakness In Lower-margin Commodity ProductsDeclining volumes in commodity exam gloves reduce revenue and dilute margins because these are high-volume, low-differentiation products. Structural demand elasticity and customer destocking risk could keep growth uneven and cap upside from scale in the near term.
Decline In Free Cash Flow Growth And Modest ProfitabilityA 22.7% drop in FCF growth coupled with low net margin and modest ROE constrains reinvestment and strategic optionality. Even with strong cash conversion metrics, weakening FCF growth reduces buffer for sustained buybacks, M&A or large capex without increasing leverage.
Ansell News
ANSLF FAQ
What was Ansell’s price range in the past 12 months?
Ansell lowest stock price was $16.03 and its highest was $26.39 in the past 12 months.
What is Ansell’s market cap?
Ansell’s market cap is $3.12B.
When is Ansell’s upcoming earnings report date?
Ansell’s upcoming earnings report date is Aug 24, 2026 which is in 31 days.
How were Ansell’s earnings last quarter?
Ansell released its earnings results on Feb 15, 2026. The company reported $0.663 earnings per share for the quarter, beating the consensus estimate of $0.638 by $0.025.
Is Ansell overvalued?
According to Wall Street analysts Ansell’s price is currently Undervalued.
Does Ansell pay dividends?
Ansell pays a Semiannually dividend of $0.266 which represents an annual dividend yield of 2.53%. See more information on Ansell dividends here
What is Ansell’s EPS estimate?
Ansell’s EPS estimate is 0.76.
How many shares outstanding does Ansell have?
Ansell has 140,313,830 shares outstanding.
What happened to Ansell’s price movement after its last earnings report?
Ansell reported an EPS of $0.663 in its last earnings report, beating expectations of $0.638. Following the earnings report the stock price went up 5.24%.
Which hedge fund is a major shareholder of Ansell?
Currently, no hedge funds are holding shares in ANSLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ansell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.28%
12-Months-Change
Fundamentals
Return on Equity
2.53%
Trailing 12-Months
Asset Growth
1.60%
Trailing 12-Months
Company Description
Ansell
Ansell Limited is a global enterprise that conceptualizes, innovates, and produces protective equipment for various industries across numerous regions, including Asia Pacific, Europe, the Middle East, Africa, the Americas, and the Caribbean. The company's operations are divided into two principal divisions: Healthcare and Industrial. The Healthcare division focuses on crafting and distributing products such as surgical, single-use, and examination gloves, alongside specialized cleanroom and sterile gloves and apparel. These offerings cater to a diverse clientele including medical facilities, surgical clinics, dental offices, veterinary practices, emergency services, research laboratories, and pharmaceutical and life science firms. Conversely, the Industrial segment provides hand and chemical protective gear designed for a wide array of demanding applications, from the automotive, chemical, and metal fabrication sectors to machinery, food processing, construction, mining, oil and gas industries, and first responders. Established in 1893 and headquartered in Richmond, Australia, the company was initially known as Pacific Dunlop Limited before rebranding to Ansell Limited in 2002. P. D. Holdings Pty. Ltd. currently operates as a subsidiary of Ansell Limited.
ANSLF Stock 12 Month Forecast
Average Price Target
$23.20
▲(15.41% Upside)
Technical Analysis
Nanosonics Limited
―
Medical Developments International Limited
―
Trajan Group Holdings Ltd
―
CleanSpace Holdings Ltd.
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Ownership Overview
0.17% Insiders
6.82% Mutual Funds
― Other Institutional Investors
86.26% Public Companies and
Individual Investors